rethinkPeptides Search
Menu
Home / Research library
Study breakdown

BPC-157 Both Prevents and Heals Pancreatitis and Associated Gut Damage in Rats

RPEP-003841996Sikirić, P; Seiwerth, S; Grabarević, Z; Rucman, R; Petek, M; Jagić, V; Turković, B; Rotkvić, I; Mise, S; Zoricić, I; Jurina, L; Konjevoda, P; Hanzevacki, M; Ljubanović, D; Separović, J; Gjurasin, M; Bratulić, M; Artuković, B; Jelovac, N; Buljat, G
Animal StudyModerate evidence
The takeaway

BPC-157 showed both protective and healing effects in bile duct ligation-induced pancreatitis and the accompanying stomach and duodenal damage in rats.

Both preventive and therapeutic

BPC-157 reduced pancreatitis severity when given either before or after disease onset

What the researchers found

BPC-157 demonstrated both prophylactic and therapeutic effects in bile duct ligation-induced pancreatitis, also improving concomitant gastric and duodenal lesions.

Why it matters

Acute pancreatitis has limited treatment options. A peptide that both prevents and heals pancreatic inflammation while also protecting the surrounding digestive tract addresses a significant unmet medical need.

How the study worked

Rat model of acute pancreatitis induced by bile duct ligation. BPC-157 was tested as either a pre-treatment (protective) or post-onset treatment (healing). Pancreatitis severity and gastroduodenal lesions were assessed.

What this study cannot tell us

Animal study using a surgical model of pancreatitis that may not perfectly represent human disease. Specific doses and quantitative results not detailed in abstract.

How to read the evidence

Moderate animal evidence with both prophylactic and therapeutic testing. Compelling results but limited to a surgical pancreatitis model.

When this study was published

Published in 1996, this is an early BPC-157 study expanding its known benefits to pancreatic protection.

The bigger picture

This study expanded BPC-157's documented benefits from the stomach and intestines to the pancreas, establishing it as a broad gastrointestinal protective and healing agent.

Questions still open

  • Could BPC-157 be used prophylactically in patients at high risk for pancreatitis?
  • What is BPC-157's mechanism of action in reducing pancreatic inflammation?

Common questions

What is pancreatitis?
Pancreatitis is inflammation of the pancreas — the organ that produces digestive enzymes and insulin. Acute pancreatitis can be extremely painful and potentially life-threatening, with limited specific treatments available.
Why does pancreatitis cause stomach and duodenal damage?
When the pancreas becomes inflamed, digestive enzymes can leak and damage surrounding tissues. The bile duct ligation model used here also causes bile backup that damages the stomach and duodenum, mimicking what happens in severe human pancreatitis.

Read the original research

Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats.

Digestive diseases and sciences, 41(7), 1518-26

View on PubMed ↗

Citation

Sikirić, P; Seiwerth, S; Grabarević, Z; Rucman, R; Petek, M; Jagić, V; Turković, B; Rotkvić, I; Mise, S; Zoricić, I; Jurina, L; Konjevoda, P; Hanzevacki, M; Ljubanović, D; Separović, J; Gjurasin, M; Bratulić, M; Artuković, B; Jelovac, N; Buljat, G. (1996). Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats.. Digestive diseases and sciences, 41(7), 1518-26.